Humoral response to mRNA anti–COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia

Immunocompromised individuals such as patients with chronic lymphocytic leukemia (CLL) are at risk of impaired immune responses to vaccination. The objective of our study was to evaluate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–specific antibody responses in patients with CLL aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagacean, Cristina, Letestu, Rémi, Al-Nawakil, Chadi, Brichler, Ségolène, Lévy, Vincent, Sritharan, Nanthara, Delmer, Alain, Dartigeas, Caroline, Leblond, Véronique, Roos-Weil, Damien, Tomowiak, Cécile, Merabet, Fatiha, Béné, Marie C., Clavert, Aline, Chaoui, Driss, Genet, Philippe, Guieze, Romain, Laribi, Kamel, Drénou, Bernard, Willems, Lise, Puppinck, Christian, Legendre, Hugo, Troussard, Xavier, Malartre, Stéphanie, Cymbalista, Florence, Michallet, Anne-Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Stimulus Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632355/
https://www.ncbi.nlm.nih.gov/pubmed/34844264
http://dx.doi.org/10.1182/bloodadvances.2021006215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632355/
https://www.ncbi.nlm.nih.gov/pubmed/34844264
http://dx.doi.org/10.1182/bloodadvances.2021006215

Ejemplares similares